XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.25.3

STOCKHOLDERS’ EQUITY (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Equity [Abstract] |
SCHEDULE OF OUTSTANDING WARRANTS AND CHANGES | A summary of the status of the Company’s total outstanding warrants and changes during the nine months ended September 30, 2025 and 2024, respectively are as follows: SCHEDULE OF OUTSTANDING WARRANTS AND CHANGES
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value (1) |
Balance Outstanding on December 31, 2024 |  |  | 125,531 |  |  | $ | 4.09 |  |  |  | 3.26 |  |  | $ | 90,952 |
Issued |  |  | 2,525,835 |  |  |  | 5.37 |  |  |  | 2.84 |  |  |  | - |
Exercised |  |  | (515,678 | ) |  |  | - |  |  |  | - |  |  |  | - |
Balance Outstanding on September 30, 2025 |  |  | 2,135,688 |  |  | $ | 5.88 |  |  |  | 2.88 |  |  | $ | 2,435,901 |
Exercisable, September 30, 2025 |  |  | 2,123,188 |  |  | $ | 5.89 |  |  |  | 2.87 |  |  | $ | 2,399,026 |
(1) | The aggregate intrinsic value on September 30, 2025, was calculated based on Nasdaq’s market close on September 30, 2025 of $7.02 and the exercise price of the underlying warrants.
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value (1) |
Balance Outstanding on December 31, 2023 |  |  | 611,017 |  |  | $ | 1.00 |  |  |  | 2.5 |  |  | $ | 574,356 |
Issued |  |  | 289,751 |  |  |  | 2.70 |  |  |  | 3.0 |  |  |  | - |
Balance Outstanding on September 30, 2024 |  |  | 900,768 |  |  | $ | 1.55 |  |  |  | 2.1 |  |  | $ | 1,211,261 |
Exercisable, September 30, 2024 |  |  | 849,768 |  |  | $ | 1.64 |  |  |  | 2.3 |  |  | $ | 1,382,621 |
(1) | The aggregate intrinsic value on September 30, 2024, was calculated based on Nasdaq’s market close on September 30, 2024 of $2.89 and the exercise price of the underlying warrants. The aggregate intrinsic value on December 31, 2023 was calculated based on the difference between the calculated fair value on December 31, 2023 of $1.94 and the exercise price of the underlying warrants.
SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODEL TO WARRANTS GRANTED ASSUMPTION | The above warrants granted during the nine months ended September 30, 2025 were valued using the Black-Scholes option pricing model using the following weighted average assumptions: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODEL TO WARRANTS GRANTED ASSUMPTION
|  | September 30, 2025 |
Expected term, in years |  |  | 5 |
Expected volatility |  |  | 54.41 | %
Risk-free interest rate |  |  | 4.01 | %
Dividend yield |  |  | - |
SCHEDULE OF STOCK OPTION ACTIVITY | A summary of the Company’s stock option activity is as follows: SCHEDULE OF STOCK OPTION ACTIVITY
|  | Shares Underlying Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Contractual Life (Years) |  |  | Intrinsic Value |
Outstanding at December 31, 2024 |  |  | 322,500 |  |  | $ | 3.40 |  |  |  | 4.97 |  |  | $ | 138,675 |
Granted |  |  | 650,000 |  |  |  | 7.42 |  |  |  | 4.66 |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (8,748 | ) |  |  | 3.40 |  |  |  | - |  |  |  | - |
Outstanding at September 30, 2025 |  |  | 963,752 |  |  | $ | 6.11 |  |  |  | 4.52 |  |  | $ | 1,363,782 |
Exercisable at September 30, 2025 |  |  | 432,188 |  |  | $ | 4.06 |  |  |  | 4.20 |  |  | $ | 1,217,851 |
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS OF OPTIONS | The options granted during the nine months ended September 30, 2025 were valued using the Black-Scholes option pricing model using the following weighted average assumptions: SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS OF OPTIONS
|  | September 30, 2025 |
Expected term, in years |  |  | 4.59 |
Expected volatility |  |  | 51.36 | %
Risk-free interest rate |  |  | 3.84 | %
Dividend yield |  |  | - |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration